An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
Go back to An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2| AGENUS (NASDAQ: AGEN) | Delayed: 7.66 -0.15 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.81 | 52 Week High | $7.49 | |||
| Open | $7.98 | 52 Week Low | $2.61 | |||
| Day High | $8.07 | P/E | N/A | |||
| Day Low | $7.61 | EPS | $-1.10 | |||
| Volume | 741,162 | |||||
